Abstract
Due to a high incidence of undescended testicles, patients with Down's syndrome have an increased risk of testicular cancer. The treatment of these patients with the successful cisplatin-containing regimens, which are however toxic and require hospitalization, can cause several problems. We present a patient with Down's syndrome suffering from a disseminated seminomatous tumour of the testis who has been successfully treated with combination chemotherapy on an out-patient basis.
MeSH terms
-
Adult
-
Ambulatory Care*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carboplatin / administration & dosage
-
Carboplatin / adverse effects
-
Cryptorchidism / complications
-
Cryptorchidism / genetics
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Down Syndrome / complications*
-
Down Syndrome / genetics
-
Humans
-
Male
-
Risk Factors
-
Seminoma / drug therapy*
-
Seminoma / genetics
-
Testicular Neoplasms / drug therapy*
-
Testicular Neoplasms / genetics
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Vincristine
-
Cyclophosphamide
-
Carboplatin